Caseware UK (AP4) 2024.0.164 2024.0.164 false2024-04-01falseNo description of principal activity22truetrueThe members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006. 09416232 2024-04-01 2025-03-31 09416232 2023-04-01 2024-03-31 09416232 2025-03-31 09416232 2024-03-31 09416232 c:Director1 2024-04-01 2025-03-31 09416232 c:Director2 2024-04-01 2025-03-31 09416232 c:RegisteredOffice 2024-04-01 2025-03-31 09416232 d:Buildings d:ShortLeaseholdAssets 2024-04-01 2025-03-31 09416232 d:Buildings d:ShortLeaseholdAssets 2025-03-31 09416232 d:Buildings d:ShortLeaseholdAssets 2024-03-31 09416232 d:PlantMachinery 2024-04-01 2025-03-31 09416232 d:PlantMachinery 2025-03-31 09416232 d:PlantMachinery 2024-03-31 09416232 d:PlantMachinery d:OwnedOrFreeholdAssets 2024-04-01 2025-03-31 09416232 d:OfficeEquipment 2024-04-01 2025-03-31 09416232 d:OfficeEquipment 2025-03-31 09416232 d:OfficeEquipment 2024-03-31 09416232 d:OfficeEquipment d:OwnedOrFreeholdAssets 2024-04-01 2025-03-31 09416232 d:OwnedOrFreeholdAssets 2024-04-01 2025-03-31 09416232 d:Non-currentFinancialInstruments 2025-03-31 09416232 d:Non-currentFinancialInstruments 2024-03-31 09416232 d:CurrentFinancialInstruments d:WithinOneYear 2025-03-31 09416232 d:CurrentFinancialInstruments d:WithinOneYear 2024-03-31 09416232 d:Non-currentFinancialInstruments d:AfterOneYear 2025-03-31 09416232 d:Non-currentFinancialInstruments d:AfterOneYear 2024-03-31 09416232 d:Non-currentFinancialInstruments d:BetweenOneTwoYears 2025-03-31 09416232 d:Non-currentFinancialInstruments d:BetweenOneTwoYears 2024-03-31 09416232 d:Non-currentFinancialInstruments d:BetweenTwoFiveYears 2025-03-31 09416232 d:Non-currentFinancialInstruments d:BetweenTwoFiveYears 2024-03-31 09416232 d:ShareCapital 2025-03-31 09416232 d:ShareCapital 2024-03-31 09416232 d:RetainedEarningsAccumulatedLosses 2025-03-31 09416232 d:RetainedEarningsAccumulatedLosses 2024-03-31 09416232 c:OrdinaryShareClass1 2024-04-01 2025-03-31 09416232 c:OrdinaryShareClass1 2025-03-31 09416232 c:OrdinaryShareClass1 2024-03-31 09416232 c:FRS102 2024-04-01 2025-03-31 09416232 c:AuditExempt-NoAccountantsReport 2024-04-01 2025-03-31 09416232 c:AbridgedAccounts 2024-04-01 2025-03-31 09416232 c:PrivateLimitedCompanyLtd 2024-04-01 2025-03-31 09416232 e:PoundSterling 2024-04-01 2025-03-31 xbrli:shares iso4217:GBP xbrli:pure
Registered number: 09416232










REMEDY HOUSE LTD

Unaudited
Financial statements
Information for filing with the registrar
For the year ended 31 March 2025

 
REMEDY HOUSE LTD
 

Company Information


Directors
T G C Mitchell 
R Leckie 




Registered number
09416232



Registered office
24 Wilkinson Street

Sheffield

South Yorkshire

S10 2GB





 
REMEDY HOUSE LTD
Registered number: 09416232

Balance sheet
As at 31 March 2025

2025
2024
Note
£
£

Fixed assets
  

Tangible assets
 4 
1,402
3,040

  
1,402
3,040

Current assets
  

Debtors
  
7,198
-

Cash at bank and in hand
  
4,199
4,984

  
11,397
4,984

Creditors: amounts falling due within one year
  
(18,805)
(29,291)

Net current liabilities
  
 
 
(7,408)
 
 
(24,307)

Total assets less current liabilities
  
(6,006)
(21,267)

Creditors: amounts falling due after more than one year
  
(356)
(3,432)

Net liabilities
  
(6,362)
(24,699)


Capital and reserves
  

Called up share capital 
 8 
3
3

Profit and loss account
  
(6,365)
(24,702)

  
(6,362)
(24,699)


The directors consider that the Company is entitled to exemption from audit under section 477 of the Companies Act 2006 and members have not required the Company to obtain an audit for the year in question in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of FRS 102 Section 1A - small entities.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The Company has opted not to file the statement of income and retained earnings in accordance with provisions applicable to companies subject to the small companies' regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf on 16 September 2025.






T G C Mitchell
R Leckie
Page 1

 
REMEDY HOUSE LTD
Registered number: 09416232

Balance sheet (continued)
As at 31 March 2025

Director
Director

The notes on pages 3 to 7 form part of these financial statements.

Page 2

 
REMEDY HOUSE LTD
 

 
Notes to the financial statements
For the year ended 31 March 2025

1.


General information

Remedy House Ltd is a company limited by shares and incorporated in England within the United Kingdom. The address of the registered office is given in the company information on page 1 of these financial statements.
The financial statements are presented in sterling which is the functional currency of the company.
The significant accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all years presented unless otherwise stated. 

2.Accounting policies

 
2.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with FRS 102 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland' and the requirements of the Companies Act 2006. The disclosure requirements of Section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The members have agreed to the preparation of abridged accounts for this accounting period in accordance with Section 444(2A) of the Companies Act 2006.

 
2.2

Revenue

Revenue is measured at the fair value of the consideration received or receivable and is accounted for in the period in which the income is due.

 
2.3

Operating leases: the Company as lessor

Rental income from operating leases is credited to profit or loss on a straight-line basis over the lease term.

 
2.4

Operating leases: the Company as lessee

Rentals paid under operating leases are charged to profit or loss on a straight-line basis over the lease term.

 
2.5

Finance costs

Finance costs are charged to profit or loss over the term of the debt using the effective interest method so that the amount charged is at a constant rate on the carrying amount. Issue costs are initially recognised as a reduction in the proceeds of the associated capital instrument.

 
2.6

Borrowing costs

All borrowing costs are recognised in profit or loss in the year in which they are incurred.

 
2.7

Taxation

Tax is recognised in profit or loss except that a charge attributable to an item of income and expense recognised as other comprehensive income or to an item recognised directly in equity is also recognised in other comprehensive income or directly in equity respectively.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the balance sheet date in the countries where the Company operates and generates income.


Page 3

 
REMEDY HOUSE LTD
 

 
Notes to the financial statements
For the year ended 31 March 2025

2.Accounting policies (continued)

 
2.8

Tangible fixed assets

Tangible fixed assets under the cost model are stated at historical cost less accumulated depreciation and any accumulated impairment losses. Historical cost includes expenditure that is directly attributable to bringing the asset to the location and condition necessary for it to be capable of operating in the manner intended by management.

Depreciation is charged so as to allocate the cost of assets less their residual value over their estimated useful lives, using the straight-line method.

Depreciation is provided on the following basis:

Leasehold improvements
-
in accordance with the estimated useful life of the property
Plant and machinery
-
20%
straight line
Computer equipment
-
33%
straight line

The assets' residual values, useful lives and depreciation methods are reviewed, and adjusted prospectively if appropriate, or if there is an indication of a significant change since the last reporting date.

Gains and losses on disposals are determined by comparing the proceeds with the carrying amount and are recognised in profit or loss.

 
2.9

Debtors

Short-term debtors are measured at transaction price, less any impairment. Loans receivable are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method, less any impairment.

 
2.10

Cash and cash equivalents

Cash is represented by cash in hand and deposits with financial institutions repayable without penalty on notice of not more than 24 hours. Cash equivalents are highly liquid investments that mature in no more than three months from the date of acquisition and that are readily convertible to known amounts of cash with insignificant risk of change in value.

 
2.11

Creditors

Short-term creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method.

 
2.12

Financial instruments

The Company has elected to apply the provisions of Section 11 “Basic Financial Instruments” of FRS 102 to all of its financial instruments.

Basic financial assets

Basic financial assets, which include trade and other debtors, cash and bank balances, are initially measured at their transaction price (adjusted for transaction costs except in the initial measurement of financial assets that are subsequently measured at fair value through profit and loss) and are subsequently carried at their amortised cost using the effective interest method, less any provision for impairment, unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest.

Discounting is omitted where the effect of discounting is immaterial. The Company's cash and cash equivalents, trade and most other debtors due with the operating cycle fall into this category of financial instruments.

Page 4

 
REMEDY HOUSE LTD
 

 
Notes to the financial statements
For the year ended 31 March 2025

2.Accounting policies (continued)


2.12
Financial instruments (continued)

Financial liabilities

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the Company after the deduction of all its liabilities.

Basic financial liabilities, which include trade and other creditors, bank loans and other loans are initially measured at their transaction price (adjusting for transaction costs except in the initial measurement of financial liabilities that are subsequently measured at fair value through profit and loss). When this constitutes a financing transaction, whereby the debt instrument is measured at the present value of the future payments discounted at a market rate of interest, discounting is omitted where the effect of discounting is immaterial.

Debt instruments are subsequently carried at their amortised cost using the effective interest rate method.

Trade creditors are obligations to pay for goods and services that have been acquired in the ordinary course of business from suppliers. Trade creditors are classified as current liabilities if the payment is due within one year. If not, they represent non-current liabilities. Trade creditors are initially recognised at their transaction price and subsequently are measured at amortised cost using the effective interest method. Discounting is omitted where the effect of discounting is immaterial.


3.


Employees

The average monthly number of employees, including directors, during the year was 2 (2024 -2).


4.


Tangible fixed assets





Leasehold improvements
Plant and machinery
Computer equipment
Total

£
£
£
£



Cost or valuation


At 1 April 2024
24,318
180
10,822
35,320



At 31 March 2025

24,318
180
10,822
35,320



Depreciation


At 1 April 2024
21,278
180
10,822
32,280


Charge for the year on owned assets
1,638
-
-
1,638



At 31 March 2025

22,916
180
10,822
33,918



Net book value



At 31 March 2025
1,402
-
-
1,402



At 31 March 2024
3,040
-
-
3,040

Page 5

 
REMEDY HOUSE LTD
 

 
Notes to the financial statements
For the year ended 31 March 2025

5.


Cash and cash equivalents

2025
2024
£
£

Cash at bank and in hand
4,199
4,984

4,199
4,984



6.


Creditors: Amounts falling due after more than one year

2025
2024
£
£

Bank loans
356
3,432

356
3,432



7.


Loans


Analysis of the maturity of loans is given below:


2025
2024
£
£

Amounts falling due within one year

Bank loans
3,143
3,067


3,143
3,067

Amounts falling due 1-2 years

Bank loans
356
3,145


356
3,145

Amounts falling due 2-5 years

Bank loans
-
288


-
288


3,499
6,500



8.


Share capital

2025
2024
£
£
Page 6

 
REMEDY HOUSE LTD
 

 
Notes to the financial statements
For the year ended 31 March 2025

8.Share capital (continued)

Allotted, called up and fully paid



3 (2024 -3) Ordinary shares of £1.00 each
3
3



9.


Related party transactions

The company is in receipt of loans from companies for  which the Directors are Directors and shareholders . The amount outstanding at the financial year end was £12,770 (2024: £17,540).


Page 7